Chad Nicholson
Interventional Cardiology · Dickson, TNNPI 1700362241
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $3,583 and has fallen 53.6% since, to $1,661 in 2025.
Across 168 payments — averaging $54.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Inari Medical, Inc.$2K
- Amgen$968
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$925
- Medtronic$574
- Abiomed$468
- plus $3K from 25 others
What the payments were for
- Travel & lodging$5686%
- Food & beverage$8,26991%
- Education$2753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 32 | $1,676 |
| Inari Medical, Inc. | 24 | $1,668 |
| Amgen | 8 | $968 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 22 | $925 |
| Medtronic | 7 | $574 |
| Abiomed | 5 | $468 |
| Boston Scientific | 9 | $298 |
| Penumbra, Inc. | 3 | $295 |
| E.r. Squibb & Sons, L.L.C. | 2 | $249 |
| Shockwave Medical, Inc | 5 | $244 |
| Merck | 6 | $242 |
| Sanofi | 2 | $233 |
| Edwards Lifesciences | 6 | $196 |
| Chiesi USA, Inc. | 7 | $168 |
| United Therapeutics Corporation | 1 | $125 |
| Pfizer | 5 | $113 |
| Philips North America LLC | 1 | $111 |
| Boehringer Ingelheim | 2 | $110 |
| AstraZeneca | 4 | $84 |
| Stryker | 3 | $66 |
| Novartis | 3 | $48 |
| Lantheus Medical Imaging, Inc. | 2 | $40 |
| Angiodynamics, Inc. | 1 | $40 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $39 |
| Reflow Medical Inc | 1 | $24 |
| Bayer | 1 | $23 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Imperative Care, Inc | 1 | $19 |
| Bridgebio Pharma, Inc. | 1 | $18 |
| Teleflex LLC | 1 | $15 |
| Janssen Scientific Affairs, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$1,146
- CT THROMBECTOMY SYSTEM KIT$1,146
- Repatha$968
- HawkOne$361
- Penumbra System$277
- ENSITE$230
- LifeVest$203
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$153
- FABRAZYME$150
- CARDIOMEMS$148
- ENSITE PRECISION$145
- Impella$145
- PERCLOSE PROGLIDE$137
- CAMZYOS$125
- TYVASO$125
- ELIQUIS$124
- COREVALVE EVOLUT R$121
- XIENCE SIERRA$116
- (5027) Intact Vascular Undivided$111
- Perclose ProStyle$106
How this compares
$9,113 in reported general payments places this provider in the 55th percentile of 207 interventional cardiology providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 41 | $803 |
| Atorvastatin Calcium | 14 | $252 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Dickson
- Jimmy KerriganNashville$644K
- Kashish GoelNashville$558K
- Brian JeffersonNashville$547K
- Malcolm FosterKnoxville$413K
- Mehul PatelGermantown$382K
- Michael MorseNashville$353K
- Nadia SuttonNashville$344K
- Ayaz RahmanKnoxville$251K
- Samuel HorrNashville$246K
- Joseph WeinsteinMemphis$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.